Pretax income is the income that a company earns before paying income taxes. Natera's pretax income for the
three
months ended in Dec. 2023 was $-78 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-435 Mil.
Natera's pretax margin was -25.02%.
During the past 11 years, Natera's highest Pretax Margin was -3.23%. The lowest was -75.32%. And the median was -48.38%.
Natera Pre-Tax Income Historical Data
The historical data trend for Natera's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Natera's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natera's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Natera's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Natera's Pre-Tax Income falls into.
Natera Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Natera's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-435 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natera (NAS:NTRA) Pre-Tax Income Explanation
Natera's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 11 years, Natera's highest Pretax Margin was -3.23%. The lowest was -75.32%. And the median was -48.38%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natera Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Natera's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NTRA has been successfully added to your 